Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-04-28 | James B. Hawkins joined Natus Medical Incorporated where he currently serves as President, Chief Executive Officer, and Director in April 2004. Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Prior to joining Natus Medical, Mr. Hawkins was President, Chief Executive Officer, and a Director of Invivo Corporation, a developer and manufacturer of multi-parameter vital sign monitoring equipment, and its predecessor, from 1985 through January 2004. Mr. Hawkins also served as Secretary of Invivo from 1986 until January 2004. |
| 2009-05-04 | James B. Hawkins has served as a director of the Company since October 2007. Mr. Hawkins joined Natus Medical Incorporated where he currently serves as President, Chief Executive Officer, and director in April 2004. Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Prior to joining Natus Medical, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a developer and manufacturer of multi-parameter vital sign monitoring equipment, and its predecessor from 1985 through January 2004. Mr. Hawkins also served as Secretary of Invivo from 1986 until January 2004. |
| 2010-05-07 | James B. Hawkins has served as a director of the Company since October 2007. Mr. Hawkins is independent and has extensive experience in the medical device industry. Mr. Hawkins has over two decades of experience as CEO of successful medical device companies and an intimate familiarity with the operation and management of IRIDEX. His education provides him with the financial acumen necessary to serve on our Audit Committee. Mr. Hawkins also brings to the board strong consensus-building skills and a functional understanding of the role of the board of directors, which he developed through his service on the board of directors of public companies. |
| 2011-04-29 | James B. Hawkins has served as a director of the Company since October 2007. Since April 2004, Mr. Hawkins has served as the President, Chief Executive Officer, and a director of Natus Medical Incorporated, a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Prior to joining Natus Medical, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a developer and manufacturer of multi-parameter vital sign monitoring equipment, and its predecessor from 1985 through January 2004. Mr. Hawkins also served as Secretary of Invivo from 1986 until January 2004. Mr. Hawkins holds an undergraduate degree in Business Commerce from Santa Clara University and holds a M.B.A. from San Francisco State University. Mr. Hawkins is independent and has extensive experience in the medical device industry. Mr. Hawkins has over two decades of experience as CEO of successful medical device companies and an intimate familiarity with the operation and management of IRIDEX. His education provides him with the financial acumen necessary to serve on our Audit Committee. Mr. Hawkins also brings to the board strong consensus-building skills and a functional understanding of the role of the board of directors, which he developed through his service on the board of directors of public companies. |
| 2012-04-27 | James B. Hawkins has served as a director of the Company since October 2007. Mr. Hawkins is independent and has extensive experience in the medical device industry. Mr. Hawkins has over two decades of experience as CEO of successful medical device companies and an intimate familiarity with the operation and management of IRIDEX. His education provides him with the financial acumen necessary to serve on our Audit Committee. Mr. Hawkins also brings to the board strong consensus-building skills and a functional understanding of the role of the board of directors, which he developed through his service on the board of directors of public companies. The Audit Committee of the Board consists of Messrs. Fitch and Hawkins and Dr. Garrettson. The Nominating and Governance Committee of the Board consists of Messrs. Moore and Hawkins, and Dr. Naumann-Etienne. |
| 2013-04-26 | The Audit Committee of the Board consists of Messrs. Fitch and Hawkins and Dr. Garrettson. Mr. Hawkins received fees earned or paid in cash of $30,988 and stock awards of $19,999, total $50,986. |
| 2014-04-25 | James B. Hawkins has served as a director of the Company since October 2007. Mr. Hawkins is independent and has extensive experience in the medical device industry. Mr. Hawkins has over two decades of executive experience in successful medical device companies and a familiarity with the operation and management of IRIDEX. His education and executive experience provides him with the financial acumen necessary to serve on our Audit Committee. Mr. Hawkins also brings to the board strong consensus-building skills and a functional understanding of the role of the board of directors, which he developed through his service on the board of directors of public companies. The following table provides information concerning the compensation paid by us to each of our non-employee directors for fiscal 2013. James B. Hawkins received $32,000 in cash and $30,505 in stock awards, totaling $50,986. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-10-19 | Mr. Hawkins did not serve on the Board of Directors in fiscal year 2015 and therefore received no compensation from the Company in fiscal 2015. |
| 2016-10-21 | The Audit Committee currently consists of four independent directors 6 Messrs. Good, Luskin and Hawkins and Dr. Ballhaus. The Board of Directors has determined that, based upon his work experience, Mr. Good qualifies as an "Audit Committee Financial Expert" as this term has been defined under the rules and regulations of the SEC. |
| 2017-10-23 | James B. Hawkins(1)(3)(5) 61 Director 2015 ...The Audit Committee currently consists of four independent directors 6 Messrs. Good, Luskin and Hawkins and Dr. Ballhaus. ...During the fiscal year ended June 30, 2017, each member of the Nominating and Governance Committee received $3,000 for each Nominating and Governance Committee meeting attended. ...The Technology Committee currently consists of three independent directors 6 Dr. Ballhaus and Messrs. Hawkins and Chizever. ...The following table provides compensation information for the fiscal year ended June 30, 2017 for each non-employee member of our Board of Directors: James B. Hawkins Fees Earned or Paid in Cash: $95,000 Stock Awards: $157,924 Total: $252,924. |
| 2018-10-19 | The Audit Committee currently consists of four independent directors – Messrs. Good, Luskin and Hawkins and Dr. Ballhaus. |
| 2019-10-22 | The Audit Committee currently consists of four independent directors 6 Messrs. Good, Luskin and Hawkins and Dr. Ballhaus. The Board has determined that, based upon his work experience, Mr. Good qualifies as an "Audit Committee Financial Expert" as this term has been defined under the rules and regulations of the SEC. Information regarding Mr. Good's work experience is set forth above under "Election of Directors." To date, no determination has been made as to whether the other members of the Audit Committee also qualify as Audit Committee Financial Experts. |
| 2020-10-21 | James B. Hawkins has been a member of our Board since December 2015. From 2004 through July 2018, Mr. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Natus Medical Incorporated, a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Prior to joining Natus, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a provider of MRI-safe patient monitoring. Mr. Hawkins currently serves as a director of Iradimed Corporation. Mr. Hawkins has extensive risk management experience gained through the various executive and board positions that he has held. He earned his undergraduate degree in Business Commerce from Santa Clara University and holds a Masters of Business Administration degree from San Francisco State University. Mr. Hawkins was selected to serve as a director because of his direct management experience in the medical device area. |
| 2021-10-21 | James B. Hawkins(2)(3)(5) 65 Director 2015 (2) Member of Compensation Committee (3) Member of Nominating and Governance Committee (5) Member of the Technology Committee During the fiscal year ended June 30, 2021, each non-employee director that served as a director for the full fiscal year received $48,000 and an RSU grant valued at $150,000. |
| 2022-10-26 | James B. Hawkins Independent Director Director since December 2015 BOARD COMMITTEES Compensation and Benefits Nominating and Governance Technology (Co-Chair) CAREER HIGHLIGHTS From 2004 through July 2018, Mr. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Natus Medical Incorporated. DIRECTOR COMPENSATION James B. Hawkins 138,500 194,961 333,461 |
| 2023-10-27 | James B. Hawkins Independent Director Director since December 2015 BOARD COMMITTEES Audit (Chair) Compensation and Benefits Nominating and Governance Technology CAREER HIGHLIGHTS From 2004 through July 2018, Mr. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Natus Medical Incorporated. The following table provides compensation information for the fiscal year ended June 30, 2023 for each non- employee member of our Board: James B. Hawkins Fees Earned or Paid in Cash ($) 144,000 Stock Awards ($) 212,547 Total ($) 356,547 |
| 2024-10-25 | James B. Hawkins Independent Director Director since December 2015 BOARD COMMITTEES Audit (Chair) Compensation and Benefits Nominating and Governance Technology CAREER HIGHLIGHTS From 2004 through July 2018, Mr. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Natus Medical Incorporated. BOARD COMMITTEES Audit (Chair) Compensation and Benefits Nominating and Governance Technology The following table provides compensation information for the fiscal year ended June 30, 2024 for each non- employee member of our Board: James B. Hawkins 154,000 Fees Earned or Paid in Cash 199,971 Stock Awards Total 353,971 |
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-08 | James B. Hawkins Age 57 Director since 2012 President, Chief Executive Officer and Director, Natus Medical, Inc. Committees: Audit, Compensation (Chairman) Mr. Hawkins has over two decades of experience as chief executive of successful medical device companies. Since April 2004, Mr. Hawkins has served as the President, Chief Executive Officer and a director of Natus Medical Incorporated, a provider of healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Committees: Audit, Compensation (Chairman) Non-Employee Director Compensation Table James B. Hawkins (4) Fees Paid in Cash ($) 45,000 Stock Awards $ — Option Awards $ — Non-Equity Incentive Plan Compensation ($) — Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) — All Other Compensation ($) — Total ($) 45,000 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22